Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Long-Term Investments (2019 - 2025)

Historic Long-Term Investments for Inspire Medical Systems (INSP) over the last 7 years, with Q4 2025 value amounting to $96.3 million.

  • Inspire Medical Systems' Long-Term Investments rose 3568.56% to $96.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $96.3 million, marking a year-over-year increase of 3568.56%. This contributed to the annual value of $96.3 million for FY2025, which is 3568.56% up from last year.
  • As of Q4 2025, Inspire Medical Systems' Long-Term Investments stood at $96.3 million, which was up 3568.56% from $88.4 million recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' Long-Term Investments ranged from a high of $113.4 million in Q3 2024 and a low of $204000.0 during Q1 2021
  • For the 5-year period, Inspire Medical Systems' Long-Term Investments averaged around $42.0 million, with its median value being $26.3 million (2024).
  • Its Long-Term Investments has fluctuated over the past 5 years, first crashed by 9667.7% in 2021, then soared by 470196.08% in 2022.
  • Quarter analysis of 5 years shows Inspire Medical Systems' Long-Term Investments stood at $9.9 million in 2021, then fell by 1.43% to $9.8 million in 2022, then dropped by 6.67% to $9.1 million in 2023, then surged by 676.5% to $71.0 million in 2024, then surged by 35.69% to $96.3 million in 2025.
  • Its Long-Term Investments was $96.3 million in Q4 2025, compared to $88.4 million in Q3 2025 and $109.8 million in Q2 2025.